Author:
Manson Chris,Gordon Robert,Baldwin David
Publisher
Springer International Publishing
Reference93 articles.
1. Administration Food and Drugs (2004) Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and Paediatric Advisory Committee
2. Administration Food and Drug (2012) FDA drug and safety communication: selective serotonin inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies.
www.fda.gov/Drugs/DrugSafety/ucm283375.htm
3. Administration US Food and Drug (2012) Public health advisory: treatment challenges of depression in pregnancy and the possibility of persistent pulmonary hypertension in newborns
4. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58(1):19–36
5. Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J et al (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 18(3):246–252
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献